Cargando…

Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats

BACKGROUND: Soluble amyloid-beta oligomers (Aβo) begin to accumulate in the human brain one to two decades before a clinical diagnosis of Alzheimer’s disease (AD). The literature supports that soluble Aβo are implicated in synapse and neuronal losses in the brain regions such as the hippocampus. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hector, Audrey, Provost, Chloé, Delignat-Lavaud, Benoît, Bouamira, Khadija, Menaouar, Chahinez-Anissa, Mongrain, Valérie, Brouillette, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571363/ https://www.ncbi.nlm.nih.gov/pubmed/37833786 http://dx.doi.org/10.1186/s13195-023-01316-4

Ejemplares similares

Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
por: Dufort-Gervais, Julien, et al.
Publicado: (2020)

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
por: Sajadi, Ahmadali, et al.
Publicado: (2016)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
por: Hector, Audrey, et al.
Publicado: (2021)

The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice
por: Seok, Bong Soo, et al.
Publicado: (2018)

Correction to: The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice
por: Seok, Bong Soo, et al.
Publicado: (2019)

How do Soluble Oligomers of Amyloid β-protein Impair Hippocampal Synaptic Plasticity?
por: Li, Shaomin, et al.
Publicado: (2010)

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin
por: Shin, Thuzar M, et al.
Publicado: (2008)

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
por: Tolar, Martin, et al.
Publicado: (2021)

Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
por: Sokolov, Yuri, et al.
Publicado: (2006)

Probing the Occurrence of Soluble Oligomers through Amyloid Aggregation Scaling Laws
por: Silva, Alexandra, et al.
Publicado: (2018)

Soluble amyloid beta oligomers block the learning-induced increase in hippocampal sharp wave-ripple rate and impair spatial memory formation
por: Nicole, Olivier, et al.
Publicado: (2016)

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
por: Ferreira, Sergio T., et al.
Publicado: (2015)

Inhibition of AMPA receptor trafficking at hippocampal synapses by β-amyloid oligomers: the mitochondrial contribution
por: Rui, Yanfang, et al.
Publicado: (2010)

Amyloid Beta Peptide Slows Down Sensory-Induced Hippocampal Oscillations
por: Peña-Ortega, Fernando, et al.
Publicado: (2012)

Sex Differences in Slow-wave Electroencephalographic Activity (SWA) in Adolescent Depression
por: Lopez, Jorge, et al.
Publicado: (2012)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies
por: Bram, Yaron, et al.
Publicado: (2014)

Disruption of Amyloid Plaques Integrity Affects the Soluble Oligomers Content from Alzheimer Disease Brains
por: Jimenez, Sebastian, et al.
Publicado: (2014)

Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin
por: Townsend, David, et al.
Publicado: (2018)

Reply: Soluble oligomers or insoluble fibrils?
por: Mate de Gerando, Anastasie, et al.
Publicado: (2023)

Immunogenic properties of amyloid beta oligomers
por: Dalgediene, Indre, et al.
Publicado: (2013)

Breaking the Code of Amyloid-β Oligomers
por: Lesné, Sylvain E.
Publicado: (2013)

The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020)

Single Molecule Characterization of Amyloid Oligomers
por: Yang, Jie, et al.
Publicado: (2021)

Hippocampal Cholinergic Neurostimulating Peptide as a Possible Modulating Factor against Glutamatergic Neuronal Disability by Amyloid Oligomers
por: Sato, Toyohiro, et al.
Publicado: (2017)

Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes
por: Micci, Maria-Adelaide, et al.
Publicado: (2019)

Electroencephalographic slow wave dynamics and loss of behavioural responsiveness induced by ketamine in human volunteers
por: Sleigh, Jamie, et al.
Publicado: (2019)

Level of Consciousness Is Dissociable from Electroencephalographic Measures of Cortical Connectivity, Slow Oscillations, and Complexity
por: Pal, Dinesh, et al.
Publicado: (2020)

Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake Rat
por: O'Shea, Sean D., et al.
Publicado: (2008)

Amyloid β-Oligomers Inhibit the Nuclear Ca(2+) Signals and the Neuroprotective Gene Expression Induced by Gabazine in Hippocampal Neurons
por: Lobos, Pedro, et al.
Publicado: (2023)

Shared amyloid oligomer structure proves toxic
por: Tuma, Rabiya S.
Publicado: (2003)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

The biogenesis and biology of amyloid β oligomers in the brain
por: Ashe, Karen Hsiao
Publicado: (2020)

Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022)

Electroencephalographic Seizure or Electroencephalographic Status Epilepticus in the ICU? Is it Time to Focus Just on Electroencephalographic Status Epilepticus?
por: Joshi, Charuta
Publicado: (2021)

Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
por: Price, Katherine A, et al.
Publicado: (2014)

Rapid fast-delta decay following prolonged wakefulness marks a phase of wake-inertia in NREM sleep
por: Hubbard, Jeffrey, et al.
Publicado: (2020)

Comparison of electroencephalographic findings with hippocampal magnetic resonance imaging volumetry in dogs with idiopathic epilepsy
por: Czerwik, Adriana, et al.
Publicado: (2018)

Scale-Free Dynamics of the Mouse Wakefulness and Sleep Electroencephalogram Quantified Using Wavelet-Leaders
por: Lina, Jean-Marc, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6es54sbfnfipmtokjv4skr4ego